Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance)

UNC Libraries(2020)10.17615/h353-j627Source: DataRank Database

Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (29)IDs (PubMed, OpenAlex)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Dorothy Watson ORCID,Allison M. Deal ORCID,Lynn G. Dressler,Howard L. McLeod ORCID,Katherine C Donahue ORCID

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W4299609627

National Institutes of Health

Grant: 5U10CA180882-02

Statistics and Data Center for the Alliance for Clinical Trials in Oncology

National Institutes of Health

Grant: 3U10CA180821-02S2

Alliance for Clinical Trials in Oncology Operations Center

National Institutes of Health

Grant: 3U01GM061393-10S1

Pharmacogenetics of Anticancer Agents Research Group

FWCI

0.00

Citation Percentile

0.3%

greenLicense: http://rightsstatements.org/vocab/InC/1.0/

repositoryhttps://doi.org/10.17615/h353-j627

https://doi.org/10.1093/jnci/djv188

https://academic.oup.com/jnci/article-pdf/107/10/djv188/17313861/djv188.pdf

https://dx.doi.org/10.17615/h353-j627

https://pubmed.ncbi.nlm.nih.gov/26160883

Fields of Study

Pharmacogenetics and Drug MetabolismComputational Drug Discovery MethodsCancer Genomics and Diagnostics03 medical and health sciences0302 clinical medicine

Keywords

PharmacogenomicsCancerMedicineAllianceClinical trialOncologyLeukemiaInternal medicinePharmacologyPolitical scienceAdultAged, 80 and overMaleMiddle AgedClinical Trials, Phase III as TopicPharmacogeneticsNeoplasmsOdds RatioHumansMulticenter Studies as TopicFemaleHealthcare DisparitiesPatient ParticipationAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequalitySDG 16: 16. Peace & justiceSDG 0: Partnerships for the goals